NRX Therapeutics: Boral Capital Raises PT to $34, Maintains Buy Rating.

lunes, 16 de marzo de 2026, 3:16 pm ET1 min de lectura
NRXP--

NRX Therapeutics: Boral Capital Raises PT to $34, Maintains Buy Rating.

NRX Therapeutics: Boral Capital Raises PT to $34, Maintains Buy Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios